Crossmark

Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo

Crossref DOI link: https://doi.org/10.1186/s13046-018-0863-7

Published Online: 2018-08-13

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Zhenzhen

You, Liangshun

Wang, Lei

Huang, Xianbo

Liu, Hui

Wei, Ju ying

Zhu, Li

Qian, Wenbin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81670178, 81500110, 81500111)

National Key Research and Development Program of China (2016YFC090150X)

Research Project for Practice Development of National TCM Clinical Research Bases (JDZX2015113)

Natural Science Foundation of Zhejiang Province (CN) (LY18H160008)

Funds of Science Technology Department of Zhejiang Province (2018C03016-1)
License Information

Text and Data Mining valid from 2018-08-13
More Information

Article History

Received: 27 May 2018

Accepted: 2 August 2018

First Online: 13 August 2018

Ethics approval

: For peripheral blood samples from healthy volunteers, this experiment was approved by an independent ethics committee of The First Affiliated Hospital, College of Medicine, Zhejiang University. All animal experiments were carried out in accordance with the National Institutes of Health’s Guidelines for the Care and Use of Laboratory Animals.

: This is not applicable for this study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.